Harvey Schneier

Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety

The American Journal of Gastroenterology · 2012 · 372 citations

A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation

The American Journal of Gastroenterology · 2012 · 314 citations